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Kipar, A; Meli, M L
Abstract: Feline infectious peritonitis (FIP) is one of the most important fatal infectious diseases of cats,
the pathogenesis of which has not yet been fully revealed. The present review focuses on the biology
of feline coronavirus (FCoV) infection and the pathogenesis and pathological features of FIP. Recent
studies have revealed functions of many viral proteins, differing receptor specificity for type I and type II
FCoV, and genomic differences between feline enteric coronaviruses (FECVs) and FIP viruses (FIPVs).
FECV and FIP also exhibit functional differences, since FECVs replicate mainly in intestinal epithelium
and are shed in feces, and FIPVs replicate efficiently in monocytes and induce systemic disease. Thus,
key events in the pathogenesis of FIP are systemic infection with FIPV, effective and sustainable viral
replication in monocytes, and activation of infected monocytes. The host’s genetics and immune system
also play important roles. It is the activation of monocytes and macrophages that directly leads to the
pathologic features of FIP, including vasculitis, body cavity effusions, and fibrinous and granulomatous
inflammatory lesions. Advances have been made in the clinical diagnosis of FIP, based on the clinical
pathologic findings, serologic testing, and detection of virus using molecular (polymerase chain reaction)
or antibody-based methods. Nevertheless, the clinical diagnosis remains challenging in particular in the
dry form of FIP, which is partly due to the incomplete understanding of infection biology and pathogenesis
in FIP. So, while much progress has been made, many aspects of FIP pathogenesis still remain an enigma.
DOI: 10.1177/0300985814522077
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  23 
Abstract 24 
Feline infectious peritonitis (FIP) is currently the most relevant fatal infectious disease 25 
of cats. Despite intensive research in the field, its pathogenesis is still not completely 26 
revealed. FIP is a challenging clinical disease, with progressively worsening general 27 
symptoms, i.e. fluctuating fever, anorexia, and weight loss, in combination with a 28 
variety of additional clinical features that reflect the type and distribution of the 29 
pathological changes. Several, also very recent reviews, have been published that 30 
thoroughly cover all relevant clinical aspects of the disease.41,71,131 In the present 31 
review, we therefore focus on the pathological features of FCoV infection and FIP 32 
and the various aspects that are relevant for the pathogenesis of the disease. 33 
 34 
Keywords: Diagnosis, Feline Coronavirus, Feline infectious peritonitis, Feline 35 
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  37 
History 38 
Feline infectious peritonitis (FIP) has first been thoroughly described and named in 39 
1966, when experimental infections of healthy cats with organ material of diseased 40 
animals confirmed it as a specific, fatal infectious disease of cats, and a viral etiology 41 
was suspected.172 However, the disease syndrome had already been observed in the 42 
1950s and 60s in the USA, and even earlier, a very similar disease had been 43 
reported from cats in Naples.17,83 44 
In 1968, the viral etiology was demonstrated.165 The virus morphology suggested a 45 
coronavirus (CoV), which was finally confirmed in 1976.116,121,167 The virus was first 46 
grown in peritoneal cells of experimentally infected cats, and, after propagation in cell 47 
culture, was shown to cause FIP in 100% of intraperitoneally infected animals.123 48 
Subsequently, the macrophage cell line Felis catus whole fetus-4 (Fcwf-4) has 49 
predominantly been used for virus propagation.87,123   50 
In his recent review article, based on more than 40 years of work in the field, 51 
Pedersen speculated on the reason for the likely emergence of FIP in the 20th 52 
century. He considered as the most relevant potential factors the evolution of the 53 
feline CoV (FCoV) alongside CoV of pigs and dogs, the development of virulent FIP 54 
virus mutations from enteric FCoV that had only evolved at that stage, and the 55 
changes in keeping and especially breeding of cats due to their increasing popularity 56 
as pets.131 57 
At present, despite decades of research on its etiology, pathogenesis, transmission 58 
and prevention, FIP is still the most frequent fatal and infectious feline disease for 59 
which there is so far no effective cure. 60 
 61 
Feline Coronaviruses (FCoV) 62 
Virology 63 
FCoV are pleiomorphic enveloped, single-stranded positive sense RNA viruses with 64 
an almost 30kb non-segmented genome and 11 putative open reading frames 65 
(ORF). They belong to the family Coronaviridae, order Nidovirales, and, together with 66 
Canine Coronavirus (CCV) and Transmissible Gastroenteritis Virus (TEGV) of pigs, 67 
belong to the subfamily Coronavirinae, genus Alphacoronavirus, species 68 
Alphacoronavirus 1.61 69 
At the 5’ end of the FCoV genome, approximately 20kb comprise the two overlapping 70 
ORF 1a and 1b that encode for two polypeptides which are subsequently 71 
enzymatically cleaved into 16 non-structural functional proteins mainly involved in the 72 
synthesis of the viral RNA (viral replicase). The remaining genome contains nine 73 
ORF that encode for four structural proteins (spike [S], nucleocapsid [N], membrane 74 
[M], and envelope [E]) and five group-specific, accessory proteins (3a-c, 7a and b). 75 
These are expressed individually from a nested set of subgenomic mRNAs that each 76 
contain a leader RNA sequence derived from the 5’ end of the genome, and are 77 
generated by discontinuous transcription from the 3’ end of the genome.44,46 The CoV 78 
envelope is formed by the S protein, a 180-200 kDa glycoprotein arranged in 79 
peplomers that induces the antibody response and cell mediated immunity in the 80 
host. The S peplomers are 12-24 nm long, dome shaped, and arranged like a crown; 81 
they are the key determinants of cell tropism.13 The S protein is a type I 82 
transmembrane protein with a very short C-terminal cytoplasmic tail and a long N-83 
terminal ectodomain that is divided into a N-terminal (S1) domain responsible for 84 
receptor binding, and a C-terminal (S2) domain containing the fusion peptide which 85 
mediates fusion with the target cell membrane.18 The M and E proteins are smaller 86 
surface glycoproteins and important for virus maturation, assembly, budding and 87 
interaction with the host cell. The M protein, with a mass of approximately 29 kDa, 88 
penetrates the envelope and connects it to the capsid, and participates in the RNA 89 
packaging. E proteins are type III membrane proteins of about 9 kDa that interact 90 
with the M protein in the budding compartment of the host cell.44 In mouse hepatitis 91 
virus (MHV), they can induce apoptosis.7 The N proteins have a molecular weight of 92 
approximately 50 kDa. Together with the viral RNA, they form the flexible, helical 93 
nucleocapsid and seem to be critical for viral transcription.114 Vaccine studies based 94 
on the N protein indicate that it induces cell mediated immunity and can play a 95 
protective role.82 So far, no specific function could be ascribed to the accessory 96 
proteins. The 71-72 amino acid long 3a and b proteins are well conserved among 97 
subspecies 1 alphacoronaviruses. Since they lack predicted hydrophobic segments, 98 
both are thought to be located and exert their function in the cytoplasm. ORF 3c is 99 
very well conserved among the alphacoronavirus genus and its predicted sequence 100 
indicates that it is a class III triple spanning membrane protein of 238-244 residues, 101 
with a topology similar to that of the M protein.68,115 ORF 7a encodes for a small 102 
membrane protein of approximately 10 kDa with N-terminal cleavable signal 103 
sequence and a C-terminal transmembrane domain. A recent study with deletion 104 
mutants of the homologous TGEV protein has found evidence that 7a impairs the 105 
host’s antiviral response.32 The ORF 7b is present only in FCoV, CCV and ferret CoV 106 
and encodes for a soluble glycoprotein of 207 residues (approximately 24 kDa) that 107 
has been shown to induce antibodies in naturally infected cats.76,90 108 
CoV occur in many mammalian species including humans, and in birds. They lead to 109 
acute or chronic infections and, depending on their cell tropism, induce highly 110 
variable diseases in their hosts. The host and tissue specificity is dependent on 111 
sequence variations of the S gene as well as receptor usage and distribution.46 112 
RNA viruses have high error rates in their replication and therefore occur as 113 
quasispecies, i.e. groups of related genotypes.37 With every RNA replication of CoV, 114 
several point mutations occur. Even virus “stocks” prepared from plaques form 115 
quasispecies. Genetic diversity within a quasispecies has been suggested to 116 
contribute to pathogenesis by cooperative interactions among variant viruses within a 117 
population.163 On the other hand, proofreading or repair mechanisms, mediated by 118 
the exoribonuclease in the replicase complex, allow RNA viruses to evolve whilst 119 
keeping a balance between adaptation and viral fitness.37 Also, homologous RNA 120 
recombination during mixed infections of closely related CoV strains in the same 121 
group promote cross-species transmission and pathogenesis; the cat might represent 122 
a “mixing vessel” as in vitro studies showed that feline aminopeptidase N can be 123 
used as a functional receptor by closely related alphacoronaviruses, such as FCoV, 124 
CCV, TGEV, and human coronavirus HCV-229E.158 125 
Genome sequences and subsequent phylogenetic analysis showed that FCoV 126 
isolates form geographical clusters.10-12,42,102,132 FCoV from cats of the same 127 
household exhibit over 95% genetic identity, suggesting infection from a common 128 
virus.5,102,162 Focussing on the S gene, one study specifically examined the evolution 129 
of virus strains in cohorts of naturally infected cats over several years. It 130 
demonstrated very high conservation of the virus in persistently infected and 131 
(recurrently) shedding animals, but also showed that cats can become transiently 132 
infected and subsequently re-infected with the same or a different strain. There was 133 
also evidence of super- or co-infection of persistently infected cats with other strains.5  134 
 135 
Serotypes 136 
As shown by virus neutralizing antibody reaction and amino acid sequences of the S 137 
protein, FCoV form two antigenetically distinct serotypes, type I FCoV which are 138 
difficult to grow in cell culture, and type II FCoV which are the consequence of a 139 
double recombination between type I FCoV and CCV.79,112,127,143 In vitro, the growth 140 
kinetics of both serotypes appear to be solely related to the S protein, as determined 141 
using a recombinant type I FCoV encoding a type II S protein.157 For type II FCoV, 142 
like for several other alphacoronaviruses, the cell receptor is aminopeptidase N 143 
(APN, CD13) which upon binding to the S protein, mediates the viral internalization 144 
into the target cells.81,157 Antibody blockage of APN has been shown to severely 145 
reduce the infection of bone marrow derived macrophages (BMDM) with the type II 146 
FIP strain 79-1146.140 However, it has so far not been confirmed that APN is also the 147 
receptor for FIPV II in infected animals. Furthermore, the receptor for serotype I 148 
FCoV is not known. Interestingly, however, isolated feline monocytes rapidly 149 
internalize both serotype I and II FIPV and accumulate the virus particles in 150 
endosomes, followed by particle disassembly.160 Both serotypes can use dendritic 151 
cell (DC)-specific intercellular adhesion molecule (ICAM) grabbing non-integrin (DC-152 
SIGN, CD209), a C-type lectin, which recognizes high-mannose oligosaccharides as 153 
ligands, to infect monocyte-derived dendritic cells.138 Co-localization and binding 154 
inhibition studies confirmed that DC-SIGN and not APN is involved in the entry 155 
process of serotype I FCoV in monocytes, whereas for serotype II FCoV, both APN 156 
and DC-SIGN play a role in infection of monocytes, i.e. binding is mediated by APN 157 
but DC-SIGN is important for either internalization or a subsequent step.161 In both 158 
models, a role of an unknown co-receptor cannot be excluded. 159 
Both FCoV serotypes can cause FIP, but serological and, more recently, molecular 160 
studies confirmed that type I FCoV dominate by far in the cat population worldwide, 161 
with a prevalence of up to 98%.5,80,105,107,127,143 Type I FCoV were shown to induce 162 
higher antibody titres than type II FCoV, and were more frequently associated with 163 
clinical signs and/or FIP.105 A higher type II prevalence, partly together with type I 164 
infection, has been reported for cats with FIP, ranging from 10% to more than 30%, 165 
the latter in an older study in Japan.15,42,107,143 166 
 167 
Feline Enteric Coronavirus versus Feline Infectious Peritonitis Virus 168 
FCoV occur as two pathotypes, Feline Enteric Coronavirus (FECV), defined as the 169 
“ubiquitous enteric biotype”, and Feline Infectious Peritonitis Virus (FIPV), the 170 
“virulent biotype that causes FIP in individual cats”.131 FECV and FIPV cannot be 171 
distinguished serologically or morphologically, and for many years, the search for 172 
markers that can discern the two pathotypes remained unsuccessful.  173 
In the past, it was assumed that the main difference between FECV and FIPV was 174 
that FECV exclusively infect the intestinal epithelium and do not pass the intestinal 175 
mucosal barrier, while FIPV infect and replicate in monocytes/macrophages and can 176 
therefore gain access to the blood and induce the disease.124,125,128 When more 177 
sensitive molecular methods became available, this hypothesis was proven too 178 
simple. It was shown that also FECV can infect monocytes and that FCoV generally 179 
spread from the initial site of infection, the intestine, via monocyte-associated 180 
viremia.62,94,98,109 Indeed, approximately 80% of cats, healthy or with FIP, in 181 
households with endemic FCoV infection were shown to harbor FCoV RNA in their 182 
blood monocytes, and healthy cats remained viremic over the 12 month test period.62 183 
Furthermore, it was shown recently that intraperitoneal inoculation with FECV can, 184 
albeit only occasionally, lead to virus shedding with the feces, which confirms FECV 185 
spread also from extraintestinal sites, again most likely via monocyte-associated 186 
viremia.133 187 
In order to test whether the difference between FECV and FIPV is based on the 188 
exclusive capability of FIPV to replicate in feline monocytes, a new method was 189 
developed that demonstrates replicating virus in the blood, through the specific 190 
detection of viral M protein mRNA.145 The protocol was applied in two studies on 191 
naturally infected cats and showed that FCoV can replicate within monocytes in 192 
healthy cats. However, while the first study found a strong correlation between virus 193 
replication in the blood and FIP, the second did not confirm this finding.24,145 194 
Subsequently, a quantitative method detected high levels of viral replication in cats 195 
suffering from FIP.84 Furthermore, a recent experimental study showed that after 196 
oronasal infection with known FECV isolates, only very few cats develop viremia, and 197 
without evidence of viral replication.164  198 
Initial molecular studies on FECV and FIPV isolates identified deletions in the 3c, 7a 199 
and 7b genes in FIPV and indicated that FECV are the ancestors of FIPV.89,162 Also, 200 
deletion of the 3a-c and/or 7a/7b genes from wild type FIPV II (79-1146) in an 201 
attempt to generate FIP vaccines led to the loss of virulence in experimental 202 
infections.67 This initial work was followed by a more rigorous search for virulence 203 
markers. The sequencing of structural (S, E, M, N) and accessory (3a-c, 7a and b) 204 
genes of FCoV from feces and diseased tissues of cats with FIP identified significant 205 
mutations only in the 3c gene; these resulted in variable truncation of the 3c protein. 206 
Virus with the mutated 3c gene was identified in diseased tissues, whereas the FCoV 207 
in the feces generally exhibited an intact 3c gene, and only in some cases also the 208 
mutated form.132 Together with the results of a previous study, this indicated a role of 209 
3c gene deletions in the viral switch from FECV to FIPV.132,162 However, the fact that 210 
3c gene deletions were not consistently observed with FIP suggested that additional 211 
factors are essential for the acquisition of the FIPV pathotype.162  212 
Two larger subsequent studies compared the 3c gene of FCoV from healthy cats 213 
(FECV) and cats with FIP (FIPV) to further assess its role as a virulence marker. 214 
Almost all FECV carried an intact 3c gene.28,133 After oronasal inoculation with such 215 
FECV isolates, cats became infected and shed the virus with the feces.133 In 216 
contrast, the majority (71%) of FCoV from cats with FIP exhibited 3c mutations, i.e. 217 
deletions and insertions that were sometimes associated with severe truncation and 218 
loss of function. Interestingly, FCoV identified in the feces of cats with FIP generally 219 
exhibited an intact 3c gene, which was interpreted as an indication of FECV 220 
superinfection.26 Nonetheless, similar to a previous study, both these studies 221 
identified FIPV with an intact 3c gene in diseased tissues in a substantial proportion 222 
of cats with FIP (29% and 40% respectively).26,133,162 Furthermore, the FCoV with an 223 
intact 3c gene were shown to be indeed FIPV, since they induced FIP after both 224 
oronasal and intraperitoneal inoculation.133 Interestingly, when shed with the feces, 225 
the latter was not infectious to cats.133 These findings lead to the following 226 
conclusion: FCoV need to carry an intact 3c gene to be able to sustainably replicate 227 
in the intestinal epithelium and be infective to other cats. However, an intact/non-228 
truncated 3c gene does not prevent a FCoV from inducing FIP even after oronasal 229 
inoculation. The potential significance of the observed higher frequency of non-230 
synonymous amino acid changes towards the 3’ end of FIPV with intact 3c genes 231 
needs to be further investigated.133 232 
A non-targeted approach has recently been taken in an attempt to identify further 233 
mutations that might be responsible for the change in virulence. Each 11 randomly 234 
selected FECV (from healthy cats) and FIPV (from cats with FIP confirmed by post 235 
mortem examination) were compared, based on full genome sequencing. Differences 236 
were found scattered along the entire genome, but a larger genetic variation with two 237 
hot spots was identified in the S gene. Subsequent sequencing and phylogenetic 238 
analysis of more isolates identified the two alternative codons in the S gene in more 239 
than 95% of the examined FIP cases. Both mutations occur in the supposed fusion 240 
peptide of the S protein, but without any evidence of potential functional 241 
consequences.28 However, due to the mutation rate of RNA viruses and the relative 242 
rarity of FIP, the authors concluded that the identified S gene mutations are unlikely 243 
solely responsible for the FECV-FIPV virulence switch.28  244 
A group that has worked extensively on antibody mediated enhancement (ADE) in 245 
FIP used FCoV that are resistant to virus neutralizing monoclonal antibodies to 246 
search for virulence markers. Their so-called mar-mutant viruses all exhibit mutations 247 
in several amino acids in the S1 region.91 However, when orally administered to cats, 248 
only some were found to induce FIP. None of the latter carried mutations in ORF 2-7 249 
other than those observed in the S1 region, whereas the avirulent viruses also 250 
showed deletions in the 7b gene.154 251 
A further molecular study on natural cases identified a relatively high diversity of the 252 
N protein in endemically infected cat groups, but without any pattern or relation to 253 
virulence.12 Furthermore, analysis of nucleotide substitutions identified residues in 254 
the N protein that were subjected to positive selection. These could represent 255 
antigenic immunodominant sites, indicating the antigenic role of the N protein in 256 
stimulating cell-mediated immunity.12 257 
In vitro studies complement the in vivo approaches and provide strong evidence that 258 
FCoV virulence requires the ability to productively and sustainably infect feline 259 
monocytes. This was first indicated in an older study which demonstrated less 260 
effective and shorter replication of avirulent FCoV than FIPV in feline peritoneal 261 
macrophages and was more recently confirmed in isolated feline monocytes, in 262 
which a FIPV (79-1146) established sustainable replication, whereas a FECV (79-263 
1683) could replicate, but not sustainably.38,149 It needs to be emphasized though that 264 
despite rapid virus binding, internalization and disassembly, even the replication of 265 
FIPV is limited to a very small proportion of macrophages and monocytes.38,149,160 266 
This strongly suggests that most monocytes/macrophages are resistant to the virus 267 
at the time of infection, most likely due to inhibition of genome release and/or 268 
translation.160  269 
Attempts have been made to relate the monocyte/macrophage tropism to differences 270 
in the viral protein structure. In BMDM cultures, FECV (79-1683) was shown to infect 271 
fewer cells than FIPV (79-1146) and appeared unable to spread the infection.140 This 272 
was determined by the S protein alone, and, interestingly, by the membrane-proximal 273 
S2 domain involved in virus mediated membrane fusion, and not the receptor binding 274 
S1 region.140 In agreement with these findings, a recent study found that deletions in 275 
the S1 gene region did not affect the viral capacity to productively infect feline 276 
monocytes. However, a N-terminal 29 amino acid deletion in the 7b gene lead to a 277 
decrease in virulence, although one of these mutants still retained the capacity to 278 
productively infect macrophages, suggesting that this ability is not mediated by ORF 279 
7b.154 280 
Full sequencing of the FIPV type II strain DF2 has shown that it carries a 338-nt 281 
deletion in the ORF3abc, resulting in the truncation of 3a and 3c and the complete 282 
loss of ORF3b. This virus replicated efficiently in isolated feline monocytes. When the 283 
DF2 ORF3abc was replaced with a genetically closely related, intact CCV ORF3abc 284 
region, the recombinant virus was able to replicate in feline monocytes, but yielded 285 
significantly lower virus titers.9 These results are in contrast to those of an 286 
investigation into the relevance of the ORF3 and 7 proteins for the replication of 287 
FCoV in monocytes published a year later, using the type II FIPV 79-1146, which is 288 
thought to obtain its virulence through its S protein structure but has also been shown 289 
to have a truncated 3c.35,140 The use of genetically modified viruses with deletion of 290 
ORF 3abc (FIPV-Δ3), 7ab (FIPV-Δ7) or both (FIPV-Δ3Δ7) demonstrated a lower, but 291 
sustainable replication capacity in the absence of 3, whereas viruses lacking 7ab 292 
could only undergo one replication cycle.35,67 Since ORF 7 are located at the 3’ end 293 
of the genome where transcription begins, 7a and 7b are produced very early in viral 294 
replication; it was therefore concluded that they might neutralize the innate immune 295 
response to the virus during the early phase of infection, for example by 296 
counteracting the IFN-mediated induction of an antiviral state, resulting in inhibition of 297 
viral replication.35,44 A contradiction remains to be clarified since Rottier and co-298 
workers showed in their study that mutants lacking the 7b gene could still 299 
productively replicate in macrophages and mentioned, without showing the results, 300 
that the same applied for mutated viruses lacking both 7a and 7b.140 This difference 301 
might be related to the use of different cells in both experiments, since Rottier 302 
infected BMDM, whereas the other study used peripheral blood-derived 303 
monocytes.35,140 304 
In summary, while promising, the above results from several studies do not yet 305 
provide a conclusive picture (Table 1). This is likely also due to the general diversity 306 
of the study material, in particular with regard to the virus isolates, but also the 307 
methodological approaches that have been taken.131 308 
 309 
Prevalence 310 
FIP is currently the leading infection cause of death in cats.131 However, despite the 311 
generally high prevalence of FCoV infection in the cat population, which can exceed 312 
90% in multicat environments, FIP morbidity is low and rarely surpasses 5% of 313 
infected cats.41,131 In larger cat groups, the proportion of chronic shedders and the 314 
overall frequency of virus shedding represent risk factors.50 FIP is a disease of young 315 
(6 months to 2 years), purebred, male intact cats.139 Purebred cats appear to be 316 
more susceptible also to FCoV infection in general, since they were overrepresented 317 
when healthy mixed populations were screened.48,101 A recent study indicates that 318 
the breed predilection is restricted. While Abyssinians, Bengals, Birmans, 319 
Himalayans, Ragdolls and Rexes were found to have a significantly higher risk for 320 
the development of FIP, Burmese, Exotic Shorthairs, Manxes, Persians, Russian 321 
Blues and Siamese cats did not exhibit an increased risk.134  322 
 323 
Transmission, shedding, and persistence of FCoV 324 
FCoV are transmitted via the fecal-oral route and primarily infect enterocytes.129 Cats 325 
can become persistently infected and generally remain healthy, despite systemic 326 
infection, indicating that healthy (FECV) carriers play a key role in the epidemiology 327 
of FIP.3,4,62,77,94,100,109 FCoV are shed with the feces, and carrier animals have been 328 
shown to shed the virus intermittently for months.4,49,69,78,109 Furthermore, there is 329 
evidence of a correlation between shedding frequency and intensity and high 330 
antibody titres.71  331 
Experimental studies with type I FECV isolates have demonstrated consistent 332 
shedding as early as two days and for up to 2 weeks post infection (pi), with a 333 
subsequent decline in fecal viral loads and intermittent shedding up to 20 weeks after 334 
this period.100,109,164 They confirmed previous studies in which oral administration of 335 
cell culture-adapted FIPV (Wellcome strain) led to viral antigen expression in the 336 
small and large intestine between day 1 and 7 pi, and restriction to cecum and colon 337 
on day 14.148 After clearance from the small intestine, FCoV can apparently spread 338 
from the persistently infected colon at later stages, leading to renewed shedding.100 339 
In natural FIP cases, shedding can occur until death.3,147 However, compared to 340 
diarrhoeic or healthy shedders, the amount of replicating virus shed by cats with FIP 341 
is only very low, and it is significantly lower in the gut than in organs.84,132  342 
Despite the generally strong evidence that only FECV and not FIPV are transmitted 343 
between cats, a recent study confirmed that the FCoV with a truncated 3c gene 344 
found in diseased tissues are occasionally also present in the feces of cats with 345 
FIP.132 While this would suggest that horizontal transmission is possible, a 346 
subsequent study indicated that oronasal uptake of shed, fecal FIPV does not lead to 347 
FIP.133 It remains to be clarified whether this is a universal characteristic of FIPV. 348 
This could be of relevance for epizootic FIP outbreaks, which are defined by the 349 
occurrence of FIP in more than 10% of cats in high prevalence establishments, the 350 
percentage can be lower in an environment with generally very low FIP 351 
prevalence.41,131,136 In this context, a closer look into an “artificially induced” FIP 352 
outbreak that we monitored a number of years ago is of interest. As part of a trial to 353 
investigate the efficacy of a FIP vaccine, a multicat environment similar to an animal 354 
shelter was created. This housed 40 specific pathogen free (SPF) cats (20 female, 355 
20 male neutered) to which 10 clinically healthy cats (aged 6 months to 3 years) from 356 
different animal shelters were introduced. The latter had been selected since they 357 
tested positive for circulating FCoV immune complexes.94,96,98 Within one week after 358 
introduction of the shelter cats and in which fighting for the establishment of 359 
hierarchies occurred, several animals developed transient cat flu symptoms. These 360 
subsided, but the first FIP cases occurred in week 6 (n=4), followed by a peak in 361 
weeks 7, 8 (each n=4) and 9 (n=3), with further individual cases in weeks 14 through 362 
to 22; a total of 23 animals (45%; 22 (55%) SPF cats, 1 shelter cat) succumbed to 363 
the disease. Most SPF cats that died with FIP (18; 82%) had shown previous or 364 
concurrent flu symptoms.106 Only 14 (35%) SPF cats survived the challenge period of 365 
21 weeks. They had all become infected, had shed virus at least intermittently, and 366 
exhibited histological features in the hemolymphatic tissues that indicate a strong 367 
immune response to the virus.94,96,99 The characteristics of this experimental FIP 368 
epidemic, using natural infections with field viruses, support assumptions that the 369 
occurrence of outbreaks is associated with factors related to the environment (such 370 
as crowding, concurrent infections, long-term exposure to shedders), the virus (such 371 
as virulence, replication rate and mutation rate of the strain) and the host (individual 372 
differences in the immune response to FCoV).41 It also appears likely that horizontal 373 
FIPV transmission played a role in this particular case. It might indeed be the 374 
generally low amount of FIPV that is shed with the feces if at all, and the inability of at 375 
least some FIPV shed with the feces to induce FIP that prevent more frequent 376 
horizontal transmission of the disease.132,133 377 
The main site of FCoV persistence is the colon, where viral antigen has been found 378 
in differentiated enterocytes.78,100,164 However, virus can also be detected in other 379 
tissues in the absence of viremia, and has been shown to infect tissue 380 
macrophages.100 Also, there is evidence of recurrent systemic spread.100 These 381 
findings suggest that viremia and, ultimately, FIP can develop in infected animals at 382 
any stage after initial viremia, even when the virus is cleared from the gut.100 383 
    384 
 385 
Pathologic features of FCoV infection and FIP 386 
 387 
FIP 388 
The name given to the disease in the 1960s acknowledges the consistent main gross 389 
pathological finding, a peritonitis (Figs. 1, 2). Upon gross post mortem examination, 390 
FIP is typically characterized by a fibrinous and granulomatous serositis, protein rich 391 
serous effusions and/or pyogranulomatous lesions in several organs (Fig. 1). The 392 
latter, however, are often very small and only identified by histological examination 393 
(Fig. 1e, f). Clinically, a rather clear distinction is made between an effusive (wet or 394 
non-parenchymatous) and a non-effusive (dry or parenchymatous) form of the 395 
disease, with a proportion of cases being considered in a transition stage between 396 
the two forms.41,71,131 However, the post mortem examination often identifies 397 
extensive serosal and parenchymatous granulomatous lesions in organs alongside 398 
effusions of a variable quantity (Fig. 1a-d), indicating that mixed forms are indeed 399 
more common than clinically appreciated.  400 
When the disease was first observed, several reports provided histopathological 401 
descriptions of both spontaneous and experimental cases.19,73,74,166,169-172 Several 402 
years later, a few studies attempted to categorize FIP lesions.16,92,118 Based on 403 
distribution, cellular composition, and viral antigen expression, four types of lesions 404 
were described: diffuse alterations on serosal surfaces; granulomas with and without 405 
areas of necrosis; focal and perivascular B cell and plasma cell infiltrates, and a 406 
granulomatous to necrotizing vasculitis; these can be found alongside each other.92 407 
The distribution of lesions varies in each individual case, but shows a consistent 408 
general pattern.92,96,131,172 Detailed gross, histological and immunohistological 409 
examinations that we performed on a large cohort of diagnostic cases to identify all 410 
potential lesions, confirmed peritoneal involvement in 75% of the cases, in the 411 
majority (69%) associated with abdominal effusion (Fig. 2), sometimes also with 412 
effusion in the thorax. Among organs, the kidneys were affected most often, followed 413 
by brain and eyes (Fig. 2). The latter were always involved alongside the brain, and 414 
in a subsequent study that thoroughly examined confirmed FIP cases for the 415 
presence of ocular lesions, 29% (25/86) showed involvement of the eye, in the 416 
majority of cases (68%) bilateral (M. Weber, unpublished data), suggesting that the 417 
actual involvement of the eyes is generally underestimated.131 FIP lesions are 418 
occasionally seen at unusual sites, such as the tunica vaginalis in cats with 419 
peritonitis, the skin or the testicle.23,34,144 420 
Interestingly, the general distribution of the FIP vasculitis is relatively limited. It mainly 421 
affects small and medium sized veins in leptomeninges, renal cortex (stellate veins) 422 
and eyes (mainly venules in iris, chorioidea and retina), less frequently in lungs and 423 
liver.97  424 
For natural FIP cases, an incubation period is not known. However, we gathered 425 
some information on the time log between the onset of FCoV exposure and overt 426 
disease; when we introduced several FCoV carriers into a large group of SPF cats 427 
housed together in a shelter-like multicat environment, the first clinical signs of FIP 428 
were detected after 6 weeks.106 After experimental infection, however, the incubation 429 
period has been shown to range between 2 and 14 days for the effusive and several 430 
weeks for the dry form.36,123  431 
The clinical course of FIP in natural cases is usually quite rapid for the wet form, but 432 
can take several weeks in particular for the dry form.131 We observed a clinical 433 
course of 6 to 42 days (average: 14 days) prior to death in the above mentioned 434 
group of naturally infected SPF cats.106 However, evidence of subclinical or 435 
protracted disease over a period of weeks to months has been reported.131 Also, an 436 
experimental longitudinal study demonstrated recurring waves of clinical disease, 437 
where fever and weight loss coincided with T cell depletion and increased viral loads 438 
in the blood.36 From such data, histological findings suggestive of “disease waves” 439 
would be expected, and indeed, these can be observed. As reported, the typical 440 
serosal FIP lesions often exhibit an underlying layer of B cells and plasma cells, and 441 
some of the latter contain FCoV-specific antibodies.92 We observed occasional 442 
natural cases with serosal lesions dominated by a thick plasma cell layer and 443 
evidence of granulation tissue formation with superficial granulomas and/or a 444 
fibrinous exudate (Figs. 3, 4). There is histological evidence that in FIP granulomas, 445 
macrophages are progressively replaced by B cells and plasma cells and that the 446 
typical FIP perivasculitis can develop into the focal and perivascular B cell and 447 
plasma cell infiltrates that are frequently observed, for example, in leptomeninx and 448 
mesentery.92,97 These findings indicate that the humoral immune response can limit 449 
disease progression at least to some extent or for a limited time. 450 
The typical FIP vasculitis is a phlebitis, mediated and dominated by activated virus 451 
infected monocytes, with only few T cells and neutrophils. On the basis of these 452 
features it can be distinguished from an immune mediated vasculitis, including an 453 
immune complex vasculitis.97 However, in fulminant cases, necrosis of the vessels 454 
has been seen.19,73,169 Interestingly, such an acute necrotizing vasculitis can 455 
occasionally be observed in veins with apparent previous changes (Fig. 5) which 456 
further confirms the multiphasic nature of the disease. However, due to the 457 
morphological features of the acute vascular lesions, it also provides evidence that a 458 
type III hypersensitivity reaction does contribute to the pathogenesis at least in some 459 
cases.19,73,111,169,170  460 
It has long been suspected that some cats can survive clinical FIP.126 In the above-461 
mentioned longitudinal experimental study, the majority of cats died from FIP, but 462 
several animals that had undergone one or more episodes of clinical disease 463 
survived the 4-month study period and were seen to be “free of lesions” post 464 
mortem.36 Similarly, in our longitudinal study undertaken on naturally infected SPF 465 
cats, a proportion of SPF cats became infected but survived the experiment despite 466 
consistent direct contact with virus shedding carriers for 7.5 months, from the age of 467 
21 weeks onwards.94,106,109 All survivors had remained clinically healthy throughout 468 
the experiment, apart from two cats that had developed uveitis. This did not resolve 469 
in one animal which also showed transient non-specific clinical symptoms. The post 470 
mortem examination of the latter revealed a moderate chronic B cell and plasma cell 471 
dominated leptomeningitis and perivascular encephalitis as well as a severe 472 
mononuclear conjunctivitis, iridocyclitis and perineural leptomeningitis with FCoV 473 
antibody-positive plasma cells in the infiltrates (Fig. 6). These findings support the 474 
results of an older experimental vaccine study and provide further evidence that 475 
lesions can remain limited, and that macrophages in lesions can be replaced by B 476 
cells and plasma cells with time.8,126 477 
Some animals can apparently confine the disease locally, at least for some time. One 478 
case series reported FIP lesions restricted to the mesenteric lymph nodes, and 479 
another single mural intestinal lesions, partly in association with local lymph node 480 
involvement.72,95 These findings suggest a strong local response to the virus. In the 481 
latter cases, however, progression to overt FIP was generally observed despite 482 
surgical removal of the intestinal lesions.72 483 
The lymphatic tissue of cats with FIP generally exhibits B and T cell depletion. 484 
However, in the majority of cats, this occurs with previous follicular hyperplasia and is 485 
associated with markedly increased numbers, proliferation and activation of 486 
macrophages in the splenic red pulp, lymph node sinuses and bone marrow.92,96,99  487 
 488 
Coronavirus enteritis 489 
FECV is generally regarded as the avirulent pathotype of FCoV and indeed, in older 490 
cats, oral FECV infection does lead to no or only very mild, non-specific clinical 491 
symptoms, such as transient anorexia.164 However, in young SPF kittens, at an age 492 
when animals would usually be protected by maternal antibodies, oral FECV infection 493 
can induce severe enteritis.1,125 There have also been reports of fatal coronavirus 494 
enteritis in naturally infected juvenile and adult cats. Affected cats presented with 495 
catarrhal to hemorrhagic enteritis and immunohistology confirmed that the virus 496 
infected the fully differentiated villous epithelial cells.75,93,108 497 
 498 
Coronavirus infection without FIP 499 
In an environment of high infection pressure, such as a FIP outbreak, cats become 500 
FCoV-infected and develop monocyte associated viremia and a systemic immune 501 
response to the virus, as reflected by the development of antibody and circulating 502 
immune complex titres. This is associated with distinct T and B cell hyperplasia in 503 
lymphatic tissues and the presence of plasma cells expressing FCoV-specific 504 
antibodies which does not prevent virus shedding and viral spread to 505 
tissues.94,96,100,109 A similar reaction of the lymphatic tissue has also been described 506 
after experimental FECV infections.66,109 Interestingly, it is associated with 507 
macrophage proliferation in hemolymphatic tissues, similar to, but less intense than 508 




The pathogenesis of FIP has been a research focus for several groups in Europe, the 513 
USA, and Japan. Although the picture is still not clear, the results of both in vivo and 514 
in vitro studies, though sometimes controversial, have contributed more and more 515 
pieces to the jigsaw. At present, three key features have been identified as essential 516 
prerequisites for the development of FIP lesions: systemic infection with virulent 517 
FCoV, i.e. FIPV; effective and sustainable FIPV replication in monocytes; and 518 
activation of FIPV-infected monocytes. 519 
 520 
Systemic infection with virulent FIPV 521 
Two theories have been proposed for the infection of the host; the “in vivo mutation 522 
transition” or “internal mutation” hypothesis and the “distinct circulating avirulent and 523 
virulent strains” hypothesis.21 The first model assumes that FIPV arise in vivo from 524 
mutations of FECV in infected animals, and there is indeed strong evidence that the 525 
initially acquired FCoV of most cats is not a FIPV per se. Initial comparative genome 526 
analyses of FECV and FIPV laboratory and field strains has shown these to occur as 527 
closely related pairs.76,124,162 Also, an experiment performed in chronically Feline 528 
Immunodeficiency Virus (FIV)-infected cats showed that FIPV arise de novo from the 529 
FECV inoculum.135 Furthermore, many studies demonstrated phylogenetic clustering 530 
of FIPV and FECV according to geographic distribution rather than disease 531 
phenotype.10,27,132,135,162 Finally, it is well known that although FECV are endemic in 532 
cat populations, FIP develops only sporadically, providing further strong evidence 533 
that FIPV are generally not transmitted horizontally from cat to cat, but emerge de 534 
novo in each cat that succumbs to FIP.131  535 
FCoV exhibit in vivo genetic diversity, as shown by the frequent occurrence of viral 536 
quasispecies both in individual infected animals and in infected cats from the same 537 
household.11,42,64,102 Indeed, experimental infection with fecal matter of naturally 538 
FECV infected healthy cats leads to the occurrence of quasispecies in the large 539 
intestine of individual animals.102 In natural infections, cats with FIP showed more 540 
extensive viral quasispecies formation than healthy animals, suggesting that a higher 541 
viral mutation rate is relevant for the generation of virulent mutants.11 Surprisingly, 542 
however, recent phylogenetic analyses indicated that the observed genetic diversity 543 
mainly applies to type I FCoV, whereas type II viruses are relatively 544 
homogenous.42,107 If this were indeed the case, the results of many recent studies 545 
would be called at least partly into question. 546 
The “distinct circulating avirulent and virulent strains” hypothesis is based on 547 
phylogenetic analyses and suggests that both virulent and avirulent strains circulate 548 
in the feline population and that, independently of geographic location, sequences 549 
tend to cluster with disease phenotype.20 The occurrence of occasional FIP 550 
epidemics indicates that this theory applies sporadically, while in the majority of 551 
cases, evidence supports the internal mutation theory. 552 
 553 
Effective and sustainable FIPV replication in monocytes 554 
The second essential prerequisite for FIP appears to be the viral capacity to replicate 555 
effectively and sustainably in monocytes of the infected host. In vitro, both FECV and 556 
FIPV can replicate in isolated feline peritoneal macrophages, BMDM, and 557 
monocytes, but only FIPV undergo sustainable replication and spread the infection in 558 
the culture.38,140,149 These results support in vivo studies which have shown that 559 
FCoV infection generally leads to monocyte associated viremia, but that viral 560 
replication in the blood (i.e. in monocytes) and viral loads in tissues are generally 561 
significantly higher in association with FIP.62,84,98,109,145 Based on older experimental 562 
studies, Pedersen suspected that viral replication in monocytes is very slow at least 563 
during the first two weeks after FIPV infection, but then increases rapidly, around the 564 
time when specific antibodies occur.120,131,170 So far, this hypothesis has not been 565 
tested in experimentally infected cats. However, it has been shown that FCoV 566 
infection of cats induces macrophage/monocyte proliferation in hemolymphatic 567 
tissues.96,99 This is not associated with upregulation of cytokines that stimulate 568 
macrophage proliferation in these tissues, and could therefore represent a systemic 569 
effect of infected monocytes which we found to transcribe granulocyte-monocyte 570 
colony stimulating factor (GM-CSF) and interleukin (IL-)6, cytokines that both induce 571 
proliferation and differentiation of monocyte and neutrophil precursors, within hours 572 
after in vitro FIPV infection (Kipar, unpublished data). The proliferation of 573 
monocytes/macrophages likely ensures the supply of viral target cells, i.e. mature 574 
circulating monocytes or tissue macrophages. Proliferating macrophage populations, 575 
such as macrophages in the splenic red pulp or myelomonocytic cells in the bone 576 
marrow, appear not to replicate the virus, since viral antigen cannot been detected in 577 
these cells.96,100 Higher blood cytokine levels due to cytokine release from a larger 578 
number of infected monocytes and from macrophages in FIP lesions could account 579 
for the more pronounced proliferation and generalised activation of macrophages in 580 
hemolymphatic tissues observed in cats with FIP.99  581 
Based on the fact that FECV can also replicate at least briefly in monocytes, it was 582 
recently suggested that monocytes, rather than the intestinal epithelial cells, might be 583 
the cells in which the FECV-FIPV mutations occur.133 Given the high mutation rate of 584 
the virus, this would allow positive selection for macrophage tropism and progressive 585 
viral adaptation to replication in monocytes/macrophages.133,149 It would also suggest 586 
that viral clearance from the blood and even the intestine might not prevent recurrent 587 
viremia and possibly even the development of FIP, since persistently infected, 588 
healthy, non-viremic FECV carriers were found to bear virus in tissue macrophages, 589 
i.e. in sinus macrophages in mesenteric lymph nodes and in pulmonary intravascular 590 
macrophages (PIM).100 This indicates that macrophages in the intestine take up the 591 
virus from enterocytes and carry it to the regional lymph nodes and eventually in the 592 
blood. Viral RNA was also detected in the liver where the virus most likely infects 593 
Kupffer cells (KC).100,121 Both PIM and KC phagocytose particles from the blood, but 594 
could also replicate and release virus into the circulation or transmit it to monocytes. 595 
If the mutation and transformation of FECV to FIPV can take place in these 596 
macrophages, this could result in FIP at any time post initial infection.133 597 
 598 
Activation of FIPV-infected monocytes 599 
The morphological hallmark and initiating lesion of FIP is a granulomatous phlebitis 600 
and periphlebitis that is mediated by highly activated monocytes, most likely during a 601 
phase of high-level monocyte-associated viremia with substantial viral 602 
replication.84,97,145 Studies on natural cases have shown that the phlebitis develops 603 
through direct interaction between monocytes and activated endothelial cells. The 604 
monocytes strongly express cytokines, such as TNF-α and IL-1β, and adhesion 605 
molecules, such as CD18, that allow their interaction with activated endothelial cells, 606 
and express enzymes, such as matrix metalloproteinase-9, which dissolve the 607 
vascular basement membrane at sites of monocyte emigration; the endothelial cells 608 
appear systemically activated and the restrictive distribution of vascular lesinos, i.e. 609 
veins and in selected organs, is likely a consequence of selective responsiveness of 610 
the endothelium.97 The observed simultaneous, generalised activation of both 611 
vascular endothelial cells and macrophages in hemolymphatic tissues could be 612 
mediated by activated monocytes alone, provided they release sufficient amounts of 613 
cytokines.97,99 The latter appears likely, considering also that cats with FIP show 614 
increased VEGF transcription in (virus infected) monocytes and increased serum 615 
VEGF levels.155 Furthermore, peritoneal exudate cells (PEC) of cats with FIP exhibit 616 
high TNF-α mRNA levels and were previously shown to release IL-1β and IL-6, and 617 
even alveolar macrophages collected by bronchoalveolar lavage from FIP cats show 618 
significant upregulation of TNF-α, GM-CSF, granulocyte (G)-CSF, IL-6 and other B 619 
cell differentiation factors, all suggesting strong generalised monocyte/macrophage 620 
activation in response to FIPV.59,60,150,152,153 621 
What ultimately triggers the fulminant monocyte activation in infected cats is not yet 622 
known. However, FIPV infection of the monocytes is apparently an essential 623 
prerequisite, which was recently shown in vitro in isolated feline monocytes and 624 
macrophages. FIPV rapidly induced activation of the p38 mitogen-activated protein 625 
kinase (MAPK), which directly regulates the expression of proinflammatory cytokines 626 
via phosphorylation of a range of signaling molecules, in PBMC, likely early during 627 
entry and, though less intensely, between 6 and 12 hpi, when virus is being 628 
produced.38,104,137 This was associated with the induction of TNF- and IL-1, but not 629 
IL-6 production, as demonstrated in the PBMC supernatant at 24 hpi.137 VEGF 630 
transcription was shown to be significantly upregulated at 48 hpi in isolated feline 631 
monocytes and alveolar macrophages, and feline alveolar macrophages showed 632 
increased TNF- production at 48 and 72 hpi, all exclusively in association with viral 633 
replication.155 A similar increase was seen for G-CSF and GM-CSF transcription at 634 
72 hpi; however, upregulation only became significant and TNF- and VEGF levels 635 
were further increased, when cells were inoculated with virus in combination with an 636 
antibody against the FCoV S protein that is known to induce ADE.147,152,153,155 637 
 638 
The immune system in FIP and FCoV infection 639 
With the aim to identify the role of the immune system in the pathogenesis of FIP, the 640 
blood cytokine transcription (IL-4, IL-6, IL-10, IL-12 p40, IL-18, IFN-γ, TNF-α) was 641 
monitored in experimentally infected animals. A first study reported an initial mild 642 
increase in IL-6 and IFN-γ transcription in PBMC that correlated with transient 643 
pyrexia, followed by a drop of all other examined cytokines and IFN-γ, possibly as a 644 
consequence of the lymphopenia that developed simultaneously.63 A second study 645 
demonstrated TNF-α upregulation during the development of FIP.103 Another group 646 
then screened serum VEGF levels by ELISA and found an increase in association 647 
with body effusions.155 In natural FIP cases, at the time of death, the blood showed 648 
very high interindividual variation in cytokine mRNA levels; however, IFN-γ mRNA 649 
was generally scarce or absent.53 Blood IFN-γ levels of FIP cats were then found to 650 
be similar to those of healthy carriers, but high IFN-γ concentrations were present in 651 
effusions.56 These were considered a likely consequence of the observed IFN-γ 652 
transcription within lesions.16 Believed to be released by the T cells in the lesions, 653 
IFN-γ could be responsible for macrophage attraction and local activation, which 654 
would also enhance Fc receptor expression on their surface and thereby virus uptake 655 
and replication.16 In light of the above results, the generally variable pathological 656 
changes and in particular the apparent multiphasic nature of the disease, it is 657 
possible that the fulminant monocyte activation, which is essential for the 658 
development of FIP vasculitis, does only occur as brief bouts, followed by a phase in 659 
which self-sustained granulomatous lesions develop. Such cytokine peaks might be 660 
missed when PBMC or whole blood are sampled on a regular basis or immediately 661 
prior to death. 662 
FCoV infection of cats, regardless of the development of FIP, initiates a humoral 663 
immune response, as evident by the development of antibody titres and, 664 
morphologically, the formation of secondary follicles in lymphatic tissues, and by the 665 
presence of FCoV-specific antibodies within plasma cells both in lymphatic tissues 666 
and in older FIP lesions.41,92,94,96,99,164 Some cats can eliminate the infection and then 667 
become reinfected, either with a different or the same virus strain, but tend not to 668 
develop FIP as a consequence of this.4,5,49 It is assumed that protective immunity is 669 
mainly cell mediated, and there is evidence that the development of high anti-S titers 670 
and a high S:M antibody ratio leads to virus clearance.60,131 However, in many 671 
animals, the antibodies that are formed, and in clinical FIP often with very high titres, 672 
are not able to eliminate the virus and/or the infected cells. In contrast, experimental 673 
studies provided evidence that ADE plays a role in FIP.122,127,170 FIPV ADE is based 674 
on the enhanced uptake of virus and anti-S antibody by macrophages/monocytes via 675 
the Fc receptor and can occur in vivo when immunized cats are infected with FIPV of 676 
the same serotype.29,113,151 It has however only been seen with some highly virulent 677 
FIPV and appears to be of less relevance in the natural disease.2,131 While ADE 678 
could explain the rapid spread of infection in the monocyte/macrophage population, it 679 
would not explain why the infected cells are not eliminated by the immune system. 680 
The latter can be explained by recent in vitro studies. In the presence of specific 681 
antibodies, FCoV infected isolated feline monocytes rapidly internalize the viral 682 
glycoprotein that is expressed on the surface as antigen-antibody complexes.39,40 683 
The internalization is mediated by the S and M proteins and, interestingly, does occur 684 
with both FIPV and FECV. FIPV also inhibits the complement mediated lysis of 685 
infected cells, even if they express viral antigen on their surface.30 This process is 686 
independent of the accessory 3 and 7 proteins, but the underlying mechanism has 687 
not yet been identified.30 Nonetheless, the internalization of FCoV proteins by 688 
infected cells may play a role in the pathogenesis of FIP, since the lack of an immune 689 
response that eliminates infected cells will allow more pronounced virus production 690 
and/or a quiescent infection state.39 This phenomenon could also allow the virus to 691 
persist in tissue macrophages.100 692 
As mentioned, there are marked differences between the composition and activity of 693 
the hemolymphatic tissues in FCoV-infected cats with and without FIP. Whereas 694 
healthy carriers exhibit distinct lymphoid hyperplasia with lymphocyte proliferation, 695 
FIP cats show depletion which is morphologically reflected in the often markedly 696 
depleted, though mainly secondary, lymphatic follicles, the depletion of T cell zones, 697 
and in particular the generally marked thymus atrophy.36,94,96 This is mainly a 698 
consequence of lymphocyte apoptosis, and TNF-α expression by lymphocytes, in 699 
particular in lymphatic tissues with FIP lesions, might be the underlying 700 
mechanism.33,66,96 The findings are matched by the marked blood lymphopenia 701 
observed in the terminal stage of FIP and a persistent drop in circulating CD4+ and 702 
CD8+ T cell numbers as well as an increased rate of apoptosis in PBMC in the 703 
course of the disease.33,36,150 Among PBMC, mainly CD8+ cells were shown to be 704 
affected by apoptosis, and PEC and PBMC of cats with FIP seem to produce the 705 
necessary TNF-α to mediate this.150 An in vivo study on experimentally infected cats 706 
confirms this finding, as it demonstrated increased TNF-α transcription in PBMC of 707 
cats that developed FIP, whereas animals that remained healthy had low TNF-α and 708 
high IFN-γ mRNA levels.103 High IFN-γ transcription, together with an increase in IL-709 
1β, was also seen in the blood of naturally infected healthy carriers regardless of 710 
antibody titres and virus shedding, prior to the occurrence of FIP cases in the 711 
catteries. This was considered a consequence of an increase in CD8+ T cells and 712 
coincided with the release of acute phase proteins, indicating that cytokine 713 
production by PBMC contributes to the protection of FCoV infected cats against 714 
FIP.53 715 
Despite the obvious functional differences in the T and B cell component, FCoV 716 
infection is associated with proliferation and activation of monocytes/macrophages 717 
and their precursors in hemolymphatic tissues of infected cats and, to a higher 718 
degree, cats with FIP.96 In an attempt to identify the underlying mechanism, 719 
hemolymphatic tissues of FCoV infected cats with and without FIP were assessed for 720 
the transcription of cytokines that mediate macrophage activation.99 SPF cats served 721 
to establish constitutive transcription levels, which highlighted the general flaw of any 722 
such “global expression” study; the high variability in individual transcription levels 723 
even in gender and age matched SPF animals, let alone a group as heterogeneous 724 
as naturally infected cats with FIP with regard to age, gender, disease type and 725 
stage.53,99 Nonetheless, some relevant differences in the cytokine transcription were 726 
identified. Naturally infected healthy cats exhibited significantly higher IL-10 727 
transcription levels in the spleen and lower IL-6, G- and M-CSF levels in mesenteric 728 
lymph nodes than cats with FIP, whereas FIP was associated with significantly lower 729 
IL-12 p40 mRNA levels in lymphatic tissues.99 A similar trend of reduced IL-12 p40 730 
transcription was found in lesioned vs. virus-free mesenteric lymph nodes of cats with 731 
FIP and in brains with FIP lesions.33,51 This indicates that an effective immune 732 
response together with an IL-10 mediated limitation of macrophage activation and 733 
increased cellular cytotoxicity allows infected cats to limit the viral infection and 734 
remain healthy, whereas a lack of IL-12 inhibits an effective immune response and 735 
allows monocyte/macrophage activation and ultimately FIP, probably as a 736 
consequence of impaired T cell-mediated macrophage activation.99 The fact that 737 
cytokines produced by macrophages and known to activate these and induce their 738 
proliferation (such as G-, M- and GM-CSF, IL-6, TNF-α) were not or not significantly 739 
upregulated in these tissues despite the presence of abundant activated 740 
macrophages was considered as further evidence of a systemic effect, i.e. the 741 
release of the relevant cytokines by infected, activated monocytes.99 742 
Several attempts have been made to match the pathogenesis of FIP with known 743 
immunopathogenic mechanisms. For example, FIP has long been considered an 744 
immune complex-mediated type III hypersensitivity disease, since fibrinogen and C3 745 
was demonstrated cell free and viral antigen, IgG and complement within leukocytes 746 
in vascular and focal granulomatous-necrotizing lesions. Also, cats with FIP exhibit 747 
FCoV-specific immune complexes in blood and glomerula and show high γ-globulin 748 
and C3 serum levels.85,86,117,122,169,170 However, circulating FCoV-specific immune 749 
complexes are not only found in diseased animals, but can also be detected, at least 750 
transiently, in infected cats that remain healthy.92,109 Also, the typical FIP vasculitis 751 
does not show features of immune complex vasculitis.97 While this does not confirm a 752 
type III reaction as the essential pathogenic mechanism, it does not exclude its 753 
contribution to the disease, for example in its acceleration (see above). Other authors 754 
have considered a type IV hypersensitivity reaction as the basis for the development 755 
of the granulomatous lesions, due to the dominance of CD4+ cells in the otherwise 756 
macrophage dominated lesions.16,118 In any case, the available data provide definite 757 
evidence that the immunity to FIP is cell mediated and it has been postulated that it 758 
requires viral persistence.131 Furthermore, there is evidence from both experimental 759 
and natural infections that an effective early T cell response to FCoV is essential for 760 
the prevention of FIP, since it appears to ensure the limitation of viral replication.36,119 761 
There has been a lot of speculation why cats develop the dry, the wet or a mixed 762 
form of FIP, and it is widely agreed that a strong humoral together with a very weak 763 
cellular immunity leads to the former, with lesser effusion with increasing cellular 764 
immunity.131 However, a recent study provided evidence that also the effusions are 765 
initiated by FIPV-infected monocytes/macrophages, since the latter have been shown 766 
to produce VEGF.155 VEGF is a very strong mediator of vascular permeability and 767 
does cause hyperpermeabilty also of feline vascular endothelial cells.43,155 Also, 768 
serum VEGF levels were seen to correlate with the quantity of body effusions.155 769 
These findings do not necessarily contradict the existing theories, but are very much 770 
in line with all other data that render the infected, activated monocyte the key 771 
mediator of the disease. 772 
Several studies have provided data that indicate individual differences in 773 
susceptibility to FCoV infection in general and to the effect of FIPV on monocytes. 774 
Molecular studies found evidence that individual cats can be entirely resistant to 775 
FCoV infection and that the monocytes of some cats can be completely resistant to 776 
FCoV, or to FECV alone, while the monocytes of some cats are more prone to 777 
productive FCoV infection than those of others.4,5,38,157 Finally, there appear to be 778 
differences in FIPV serotype I internalization in individual cats, suggesting that its 779 
receptor is expressed differentially between cats.160 At present, the knowledge is still 780 
lacking as to the reason for the individual differences and the key event that blocks 781 
the capability of monocytes to inhibit virus production. 782 
 783 
Diagnosis of FIP 784 
The post mortem diagnosis of FIP relies on a combination of gross and histological 785 
examination, in combination with the demonstration of viral antigen in the lesions.57 In 786 
contrast, the non-invasive ante-mortem diagnosis of FIP still remains a challenge, 787 
especially in the dry form of the disease.71,95,131 A combination of indirect and/or 788 
direct virus detection with evaluation of blood hematological and chemical parameter 789 
as well as medical history and clinical symptoms, the so-called FIP algorithm, is so 790 
far the best predictor of disease.6  791 
 792 
Host blood parameters 793 
Common blood alterations include lymphopenia, mild to moderate regenerative 794 
anemia, hyperproteinemia, and hypergammaglobulinemia. Other laboratory 795 
parameters, such as liver enzymes, bilirubin, urea and creatinine might be helpful, 796 
but high values merely reflect organ damage, which is most likely a consequence of 797 
FIP lesions.6  798 
More than the single parameters, the albumin to globulin ratio (A:G ratio) has a high 799 
diagnostic value, and at values above 0.8, FIP is extremely unlikely.6,70 A more 800 
recent retrospective study evaluating the A:G ratio showed a very poor positive 801 
predictive value (PPV) even for a cut-off value of 0.6. However, the negative 802 
predictive value (NPV) was 100% and 99% for an A:G ratio of <0.8 and <0.6%, 803 
respectively.88  804 
Recent studies have focused on the diagnostic value of an acute phase protein, 805 
alpha-1 acid glycoprotein (AGP). Serum levels are highly elevated in cats with FIP (> 806 
3 mg/ml), but are also high in other inflammatory conditions or neoplastic diseases, 807 
such as lymphoma.25,31,141 Furthermore, AGP levels may also rise in asymptomatic 808 
FCoV carriers, especially from households with endemic infection.54 However, when 809 
interpreted alongside pre-tests, i.e. epidemiological factors, clinical information and 810 
FCoV serology, moderate AGP increases are useful discrimination parameters when 811 
the probability of FIP is high, whereas with low FIP probability, only very high AGP 812 
levels support the diagnosis of FIP.120 A recent retrospective study found complete 813 
concordance between AGP levels and immunohistology in challenging diagnostic 814 
cases.54 815 
 816 
Analysis of effusions 817 
The presence of effusions facilitates the diagnosis, since tests on effusions have a 818 
higher diagnostic value than blood tests.6,70 FIP effusions typically have a very high 819 
protein content (>35 g/l), but a low cellularity (<5000 nucleated cells/ml) with a 820 
dominance of macrophages and neutrophils. When sufficient cells are present, the 821 
demonstration of viral antigen in macrophages confirms the diagnosis with a very 822 
high PPV.22,70,71  823 
The Rivalta test, commonly used to differentiate between FIP effusions and effusions 824 
due to other diseases, is not very specific. The high protein content, including fibrin 825 
and inflammatory mediators, in FIP effusions normally induces a positive reaction. 826 
However, a recent study on a large cohort of cats with effusions has shown that, 827 
while it has a high NPV, this test has a lower sensitivity, specificity, and PPV than 828 
previously reported.47,71  829 
A:G ratio can also be measured in effusions with high PPV if the ratio is <0.4, and 830 
with high NPV if the ratio is >0.8.142 Also, very good correlation exists between AGP 831 
values in effusions and serum.14 The demonstration of FCoV-specific antibodies in 832 
the effusions is only meaningful when the titre is high (≥ 1:1600), whereas the 833 
absence of antibodies has a good NPV.70 834 
 835 
Indirect virus detection: serology 836 
Serology, based on the detection of FCoV antibody titres by a range of methods 837 
(immunofluorescence, ELISA, rapid immunomigration) is widely used also 838 
commercially to assist in the diagnosis of FIP and for quarantine purposes. The tests 839 
are applied to blood and effusions, and apparent false negative results are a known 840 
problem. A recent study addressed this issue and showed a correlation of lower 841 
antibody levels in samples containing higher amounts of virus, as shown by qRT-842 
PCR.110 It was hypothesized that these false negative results were due to antibody 843 
binding to virus in the sample instead of the virus in the serological tests.110 844 
Also, a high percentage of healthy FCoV carriers are antibody-positive, of which only 845 
a small percentage develops FIP.1,146 Very high titres (≥ 1:1600) in combination with 846 
pre-tests that suggest FIP indicate an increased likelihood of FIP, unless obtained 847 
from animals in an endemic environment, such as multiple-cat households.70,130 It 848 
should also be noted that different methodological approaches and even different 849 
laboratories might yield different results from the same sample, depending on the 850 
antigen used.71 851 
Serology is generally considered a useful tool for the screening and management of 852 
catteries and quarantine purposes, in particular since antibody titres are correlated to 853 
shedding intensity and frequency.41 854 
The detection of circulating antigen-antibody complexes, for example by a 855 
competitive ELISA on serum, was shown to have a PPV of 67% and a NPV was 856 
84%.70,85 However, healthy FCoV carriers can also show circulating immune 857 
complexes.109  858 
 859 
Direct virus detection 860 
Immunohistology has been used for two decades to detect FCoV antigen in lesions 861 
and has a very high PPV.22,92,118,156 It is therefore considered the gold standard and 862 
by many diagnostic pathologists an essential component of the definite diagnosis of 863 
FIP, in particular in histologically inconclusive cases.41,57,131 For the definite ante 864 
mortem diagnosis, optimally, surgical biopsies of granulomatous lesions are used 865 
(Fig. 7), while random Tru-cut biopsies or fine needle aspirates are often not 866 
helpful.55 The demonstration of FCoV antigen in macrophages in effusions, as 867 
mentioned above, is an alternative, non-invasive tool for the intra vitam diagnosis of 868 
FIP. A positive result is highly predictive of FIP, whereas a negative result does not 869 
exclude FIP.22,70 The latter is due to both the low cellularity of the effusions and the 870 
relatively low sensitivity of the method, which can only detect heavily virus laden 871 
cells. In the authors’ experience, based on the parallel staining of cytological 872 
preparations and formalin-fixed, paraffin embedded cell pellets prepared from the 873 
effusions (minimum 1 ml), more reliable results can be obtained from the 874 
concentrated cell preparations in the pellets (Fig. 8). 875 
RT-PCR, especially real-time RT-PCR, is a sensitive method to detect virus RNA in 876 
different samples, such as feces, blood, effusions, and tissues of FCoV-infected cats 877 
and those with FIP, however, these cannot differentiate between the 878 
pathotypes.45,65,77,102 The detection of FCoV RNA in the feces is mainly used for 879 
management purposes in catteries, i.e. to determine the kinetics of viral shedding.4,41 880 
FCoV is known to spread systemically with infection, regardless of the development 881 
or presence of clinical signs of FIP; therefore, diagnostic tests that identify viremia 882 
can only be used to support other tests towards a diagnosis of FIP in cats with 883 
relevant clinical features.41,62,109 The detection of virus in effusions, however, has 884 
proven to have a high PPV, but a negative result does not exclude FIP.52,159  885 
A recent study identified two alternative amino acid differences in the putative fusion 886 
peptide of the FIPV S protein in FECV and FIPV and confirmed that together these 887 
two substitutions distinguish FIPV from FECV in >95% of cases.28 Although it cannot 888 
be excluded, due to the quasispecies nature of FCoV, that other mutation patterns 889 
could lead to disease, so far, this is the most promising potential diagnostic tool that 890 
involves the direct virus detection.11,42,64,102 Nevertheless, as these alterations are not 891 
present in the virus shed by cats with clinical FIP, any routinely employed diagnostic 892 
test based on this result will need to be sufficiently sensitive. Also, as a commercial 893 
test, a protocol would be preferable that could directly detect these mutations without 894 
the need of a further, time-consuming sequencing step. 895 
A recent publication takes previous attempts to correlate FIPV replication in 896 
monocytes with FIP further and suggests a new methodological approach for the 897 
robust simultaneous detection of virus replication and viral load, by a real time PCR 898 
based on primer-probe energy transfer.24,84,145 Rather than a tool to identify infected 899 
cats, the authors proposed this method for the identification of persistent shedders 900 
and thereby the potential sources of emerging FIP variants. Since the test was also 901 
able to reliably detect virus replication in FIP effusions, it might be useful for the 902 
confirmation of FIP at least in the wet form, provided the results are confirmed on 903 
larger case cohorts.84 904 
 905 
With increasing knowledge of the pathophysiological mechanisms that drive the 906 
virus-host interaction in FCoV infection and with the constant improvement of 907 
molecular techniques, there is reasonable hope that in the near future, the diagnostic 908 
tools for the diagnosis of FIP can be refined to specifically detect FIPV and to 909 
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Figure Legends 1419 
 1420 
Fig. 1. Gross FIP lesions. a. Cat with wet FIP, exhibiting a serofibrinous and 1421 
granulomatous serositis and granulomatous lesions in the liver (arrows). b-f. Cats 1422 
with dry FIP. b. Enlarged mesenteric lymph node with granulomatous inflammation. 1423 
c. Jejunum with multiple granulomas in the serosa. d. Jejunum with small subserosal 1424 
granulomatous lesions that follow the veins (phlebitis and/or periphlebitis; arrow). e. 1425 
Kidney with granulomatous phlebitis and periphlebitis of a Vena capsularis. f. Cat 1426 
with dry FIP and multifocal granulomatous phlebitis and periphlebitis of a cortical 1427 
leptomeningeal vein (arrow). All lesions were confirmed by subsequent histological 1428 
examination and immunohistological demonstration of FCoV antigen within the 1429 
lesions. 1430 
 1431 
Fig. 2. Distribution of FIP lesions in cats that had undergone a thorough post mortem 1432 
and histological examination for the diagnosis of FIP, including the histological 1433 
examination of all major organs and tissues and confirmation of the disease by the 1434 
immunohistological demonstration of FCoV antigen. N=77 (1N = 54; 2N = 86). 1435 
 1436 
Fig. 3. Natural FIP case with thoracic effusion and fibrinous and granulomatous 1437 
pleuritis. Pleura with inflammatory processes of variable duration. a) Overview with 1438 
dense basal layer of plasma cells (black arrowheads), overlain by layer of granulation 1439 
tissue with new vessels (arrows) and embedded macrophage dominated infiltrates 1440 
(white arrowheads) and surface layer of fibrin (*) with embedded inflammatory cells. 1441 
HE stain; Bar = 50µm. b) In another area, the basal plasma cell layer (black 1442 
arrowhead) is overlain by a loose granulation tissue with new vessels (arrows) and 1443 
occasional fibroblasts (white arrowheads). HE stain; Bar = 20µm. c) Granuloma in the 1444 
granulation tissue. FCoV antigen is present within several macrophages in the 1445 
granuloma. Horseradish peroxidase method (mouse anti-CoV, clone FCoV3-70, 1446 
Meyer’s hematoxylin counterstain.92  Bar = 20µm. 1447 
 1448 
Fig. 4. Natural FIP case with thoracic effusion and with fibrinous and granulomatous 1449 
pleuritis (see Fig. 3). Diaphragm, exhibiting a chronic plasma cell dominated (black 1450 
arrowheads) diffuse pleuritis with new vessel formation (arrows) consistent with 1451 
granulation tissue formation. Towards the surface, an infiltrate of macrophages and 1452 
neutrophils is observed (white arrowheads). Occasional macrophages are found that 1453 
express FCoV antigen (inset). HE stain and horseradish peroxidase method (mouse 1454 
anti-CoV, clone FCV3-70, Meyer’s hematoxylin counterstain (inset) .92 Bars = 20µm 1455 
(inset: Bar = 10µm).   1456 
 1457 
Fig. 5. Natural FIP case, dry form. Kidney, cortex with multiple FIP lesions. a) Stellate 1458 
vein (SV) with fibrinoid necrosis (arrows) and granulomatous vasculitis, partly 1459 
occluded by leukocytes (arrowhead). HE stain; Bar = 50µm. b) Closer view of a), 1460 
highlighting the necrosis of the vessel wall (arrows) and the infiltrate, dominated by 1461 
often degenerate macrophages. There are also focal plasma cell aggregates 1462 
(arrowhead) immediately outside the vascular wall. HE stain; Bar = 20µm. c) Closer 1463 
view of b). FCoV antigen is present within monocytes in the vascular lumen 1464 
(arrowheads) and in the vasculitis (arrow). Horseradish peroxidase method (mouse 1465 
anti-CoV, clone FCoV3-70, Meyer’s hematoxylin counterstain.92  Bar = 10µm. d) 1466 
Stellate vein distant from the vein in a)-c), exhibiting two focal perivascular plasma 1467 
cell accumulations and activated endothelial cells (arrowheads). Bar = HE stain; 1468 
20µm. 1469 
 1470 
Fig. 6. SPF cat euthanized without clinical signs and post mortem changes 1471 
consistent with FIP. The animal had been housed for 30 weeks with animals dying 1472 
from FIP and had shown a clinical episode of CNS symptoms and ocular changes 1473 
consistent with FIP. Brain, medulla oblongata. a) Mononuclear perivascular infiltrates 1474 
(arrows) in the white matter and diffuse infiltrates in the leptomeninx (*). HE stain; Bar 1475 
= 50µm. b) The infiltrate is dominated by CD45R-positive B cells. Avidin biotin 1476 
complex peroxidase method (rat anti-mouse CD45R, clone B220/Ly5, 1477 
Papanicolaou’s hematoxylin counterstain.92 Bar = 50µm. c) The perivascular infiltrate 1478 
(arrow) as well as the leptomeningeal infiltrate contains plasma cells with FCoV-1479 
specific antibodies. Peroxidase anti-peroxidase method (DF-2 FIPV suspension, 1480 
followed by mouse anti FCoV (clone FCoV3-70), Papanicolaou’s hematoxylin 1481 
counterstain.92 Bar = 10µm. 1482 
 1483 
Fig. 7. Natural FIP case, dry form. Mesenteric lymph node biopsy. a) Granulomatous 1484 
lesions are present in the serosa (*) and occasionally within the lymph node in 1485 
association with the cortical sinuses (arrow). HE stain; Bar = 50µm. b) Viral antigen is 1486 
expressed by macrophages in the serosal lesions and in parenchymal lesions (inset: 1487 
higher magnification of *). Horseradish peroxidase method (mouse anti-CoV, clone 1488 
FCoV3-70, Meyer’s hematoxylin counterstain.92  Bar = 50µm. Inset: Bar = 10µm. 1489 
 1490 
Fig. 8. Natural FIP case, wet form with abundant abdominal effusion. a) Cytological 1491 
specimen (smear) from the effusion, comprised of macrophages/mesothelial cells 1492 
(arrow) and neutrophils (arrowhead). May-Grünwald-Giemsa stain. b) Macrophages 1493 
in the smear express viral antigen. c) Macrophages in a formalin fixed and paraffin 1494 
embedded cell pellet express abundant (arrow) to small amounts (arrowhead) of viral 1495 
antigen. Horseradish peroxidase method (mouse anti-CoV, clone FCoV3-70, Meyer’s 1496 
hematoxylin counterstain.92  Bars = 10µm. 1497 
